Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
VTIP vs XLV: how they differ
VTIP and XLV hold 0% of their weight in the same names, and XLV returned more over the year.
Vanguard Short-Term Inflation-Protected Securities Index Fund and State Street(R) Health Care Select Sector SPDR(R) ETF.
What they hold in common
By the books each fund has filed, VTIP and XLV hold 0% of their money in the same securities at the same weight.
| Only in VTIP | Only in XLV |
|---|---|
| United States Treasury Inflation Indexed 5.44% | Eli Lilly & Co 16.56% |
| United States Treasury Inflation Indexed 5.38% | Johnson & Johnson 10.67% |
| United States Treasury Inflation Indexed 5.36% | AbbVie Inc 7.76% |
| United States Treasury Inflation Indexed 5.19% | UnitedHealth Group Inc 6.59% |
| United States Treasury Inflation Indexed 5.02% | Merck & Co Inc 5.54% |
| United States Treasury Inflation Indexed 4.88% | Amgen Inc 3.41% |
| United States Treasury Inflation Indexed 4.87% | Thermo Fisher Scientific Inc 3.25% |
| United States Treasury Inflation Indexed 4.79% | Abbott Laboratories 2.76% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026.
| VTIP Vanguard Short-Term Inflation-Protected Securities Index Fund | XLV State Street(R) Health Care Select Sector SPDR(R) ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | Vanguard | State Street |
| What it is | Short-Term Inflation-Protected Securities | Health care |
| Total return, 1 year | +1.7% | +20.4% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | −15.8 pts | +2.9 pts |
| Expense ratio | 0.03% | 0.08% |
| Holdings | 25 | 59 |
VTIP in plain words
VTIP is a bond fund tracking the Short-Term Inflation-Protected Securities. Over the year to Sep 11, 2026 it returned +1.7% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.03% a year.
XLV in plain words
XLV is an index equity fund tracking the Health care. Over the year to Sep 11, 2026 it returned +20.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year. By its holdings filed for Jun 30, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 59 positions, with the top ten at 61.7%. It sat 5.9% below its high of Aug 19, 2026 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, VTIP or XLV?
- In the year to Sep 12, 2026, with distributions reinvested, VTIP returned +1.7% and XLV returned +20.4%, so XLV returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, VTIP or XLV?
- VTIP charges 0.03% a year and XLV charges 0.08%, so VTIP is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, VTIP against XLV, data as of Sep 12, 2026. https://etfiq.com/compare/any/VTIP-XLV Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources